The Beneficial Effect ofl-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial | Zendy

Salman Razvi | Zendy; Lorna Ingoe | Zendy; Gill Keeka | Zendy; Crispian Oates | Zendy; Carolyn McMillan | Zendy; Jolanta U. Weaver | Zendy

Open Access

The Beneficial Effect ofl-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial

Author(s) -

Salman Razvi,

Lorna Ingoe,

Gill Keeka,

Crispian Oates,

Carolyn McMillan,

Jolanta U. Weaver

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1869

Subject(s) - medicine , subclinical infection , crossover study , thyroid function , placebo , endocrinology , brachial artery , thyroid stimulating hormone , hormone , randomized controlled trial , gastroenterology , blood pressure , alternative medicine , pathology

Subclinical hypothyroidism (SCH) is defined as raised serum TSH levels with circulating thyroid hormones within the reference range. It is uncertain whether treatment of SCH with L-thyroxine improves cardiovascular (CV) risk factors and quality of life.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research